Molecular basis of the VHL hereditary cancer syndrome
The DOI matches its Crossref record; 145 of the 146 references it cites were found in a registry or an index.
Abstract
The von Hippel-Lindau hereditary cancer syndrome was first described about 100 years ago. The unusual clinical features of this disorder predicted a role for the von Hippel-Lindau gene (VHL) in the oxygen-sensing pathway. Indeed, recent studies of this gene have helped to decipher how cells sense changes in oxygen availability, and have revealed a previously unappreciated role of prolyl hydroxylation in intracellular signalling. These studies, in turn, are laying the foundation for the treatment of a diverse set of disorders, including cancer, myocardial infarction and stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the PHDs utilize ␣-ketoglutarate as a cosubstrate and require ferrous iron (Fe 2ϩ ) and ascorbate as cofactors (Kaelin, 2002;Schofield and Zhang, 1999).”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
In the citing paper
“Since pVHL binding to the ODD domain is dependent on PHD activity (Kaelin, 2002;Safran and Kaelin, 2003)”
From Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase (2005) · cites this paper as Kaelin, 2002
Citations
Cites
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“The interaction of pVHL with HIF-α is governed by the enzymatic hydroxylation of conserved proline residues that are located within highly conserved, peptidic, pVHL-binding domains within the HIF-α subunit”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Regulation of Mammalian O 2 Homeostasis by Hypoxia-Inducible Factor 1
Semenza, G. L. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.551 · Cited by 1,914
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Self-citation
Research works printed but not linked: 5
- Collins, E. T. Intra-ocular growths (two cases, brother and sister, with peculiar vascular new growth, probably retinal, affecting both eyes). Trans. Ophthalmol. Soc. UK 14, 141–149 (1894).
- Clifford, S., Prowse, A., Affara, N., Buys, C. & Maher, E. Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom. Cancer 22, 200–209 (1998). · DOI · Paper page
- Gallou, C. et al. Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999). · DOI
- Ivan, M. et al. Biochemical purification and pharmacological inhibition of a mammalian HIF prolyl hydroxylase. Proc. Natl Acad. Sci. USA (in the press).
- Aiello, L. et al. Rapid and durable recovery of visual function in a patient with von Hippel–Lindau syndrome and optic nerve head hemangioma following systemic treatment with the VEGF receptor inhibitor SU5416. Ophthalmology (in the press).
Cited by
Items 701–800 of 864
Szkukalek, J., Dóczi, R., Dirner, A., Boldizsár, Á., Varga, Á., Déri, J., Lakatos, D., Tihanyi, D., Vodicska, B., Schwáb, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11101850 · Cited by 2
Polycystic and Other Cystic Kidney Diseases
Chapman, A. B. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-5185-5.00042-0 · Cited by 1
Urban, P. P., & Caplan, L. R. (2011) · Springer eBooks · doi:10.1007/978-3-642-04203-4_4 · Cited by 1
Hes, F. J., & Breuning, M. H. (2007) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6432-9_4 · Cited by 1
Hemangioblastoma of the Central Nervous System
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_4 · Cited by 1
Satardey, R., Yadav, R., Das, M., & Pal, D. K. (2022) · Annals of Medical Science and Research · doi:10.4103/amsr.amsr_38_22 · Cited by 1
Clinical Implications of Germline Pathogenic Variants in the VHL Gene
Friedman, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-53858-2_1 · Cited by 1
HIF Biology in RCC: Implications for Signaling, Disease Progression, and Treatment
Rathmell, W. K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2400-0_3 · Cited by 1
Targeted therapies for renal cell carcinoma
Villanueva, M. L. H., & Hauke, R. J. (2006) · Targeted Oncology · doi:10.1007/s11523-006-0041-2 · Cited by 1
Combination of Right Nephrectomy and Total Pancreaticoduodenectomy for von Hippel-Lindau Disease
Arkadopoulos, N. F., Karapanos, K., Stafyla, V. K., Yiallourou, A., Koureas, A. P., Kondi-Pafiti, A. I., & Smyrniotis, V. E. (2016) · PubMed · doi:10.6092/1590-8577/3827 · Cited by 1
Polycystic and Other Cystic Kidney Diseases
Rizk, D. V., & Chapman, A. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4617-0.00041-8 · Cited by 1
Ocular von Hippel-Lindau Disease – clinical characteristics and future directions
Abbott, A. B., Knickelbein, J. E., Wiley, H. E., Chew, E. Y., & Wong, W. T. (2016) · Expert Review of Ophthalmology · doi:10.1080/17469899.2016.1224652 · Cited by 1
Hemangioblastoma and von Hippel-Lindau Disease
Ganguly, R., Dornbos, D., Finlay, J. L., & Lonser, R. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_15 · Cited by 1
Khay, H. (2020) · International Journal of Surgery & Surgical Techniques · doi:10.23880/ijsst-16000147 · Cited by 1
Proven and less studied hematopoietic and vasoactive growth factors in retinal capillary hemangioma
Neroev, V. V., Balatskaya, N. V., Novikova, A. Y., Ryabina, M. V., & Ilyukhin, P. A. (2020) · Medical Immunology (Russia) · doi:10.15789/1563-0625-pal-2002 · Cited by 1
Paragangliomas and Pheochromocytomas
Mete, Ö., Tischler, A. S., & Asa, S. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-54391-4_12 · Cited by 1
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
Rustum, Y. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-693-6 · Cited by 2
Giordano, M., Arráez, C., & Rocco, C. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-31512-6_46-1 · Cited by 1
Binkley, E. M., & Wiley, L. A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04489-3_7 · Cited by 1
Denhardt, D. T. (2003) · PubMed · Cited by 1
Révolutions dans l’approche thérapeutique du cancer du rein
Escudier, B. J., & Gross‐Goupil, M. (2008) · médecine/sciences · doi:10.1051/medsci/20082489697 · Cited by 1
Oxygen-dependent Regulation of Transcription by the Hypoxia-inducible Factor-1
Ruas, J. L. (2005) · Figshare · Cited by 1
The Pathogenesis of Pheochromocytomas: Of Mice and Men
Korpershoek, E. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Putting Together Lesions in the Brain, Retina, Kidney and Pancreas
Silva, D. A. D., & Pan, A. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n11p990 · Cited by 1
Lu, S., Lu, K. G., Cheng, S., Hu, B., Ma, X., Nystrom, N. A., & Lu, X. (2015) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2015.7359942 · Cited by 1
Antiangiogenic Therapies in Renal Cell Carcinoma
Reckamp, K. L., Strieter, R. M., & Figlin, R. A. (2008) · Springer eBooks · doi:10.1007/978-1-84628-763-3_47 · Cited by 2
Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist
Ferguson, J. E., & Matin, S. F. (2017) · European Urology · doi:10.1016/j.eururo.2017.02.015 · Cited by 1
Caudle, J. (2013) · The Atrium (University of Guelph) · Cited by 3
Gewies, A. (2004) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.1683 · Cited by 4
Taccone, M. S., & Rutka, J. T. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_19 · Cited by 3
Hartmann, A., & Dietmaier, W. (2009) · Springer eBooks · doi:10.1007/978-3-540-29676-8_3202 · Cited by 1
The hypoxic response extends lifespan through a bioaminergic and peptidergic neural circuit
Kitto, E. S., Huang, S., Bhandari, M., Tian, C., Cox, R. L., Beydoun, S., Wang, E. Q., Shave, D., Miller, H. A., Easow, S. A., et al. (2026) · eLife · doi:10.1101/2025.05.04.652087 · Cited by 1
The hypoxic response extends lifespan through a bioaminergic and peptidergic neural circuitPreprint
Kitto, E. S., Huang, S., Bhandari, M., Tian, C., Cox, R. L., Beydoun, S., Wang, E. Q., Shave, D., Miller, H. A., Easow, S. A., et al. (2026) · eLife · doi:10.7554/elife.107651 · Cited by 1
Lawson, K. A. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27173 · Cited by 1
Pathology, Genetic Profile and Hereditary Syndromes
Kurukkal, S. N., & Al-Busaidy, S. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-16301-7_13
Erythropoietin: An Historical Overview of Physiology, Molecular Biology and Gene Regulation
Mole, D. R., & Ratcliffe, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00001-6
Development of Novel AHR Antagonists
Lee, H. (2016) · UKnowledge (University of Kentucky)
Mulibrey nanism: Characterization of hypogonadism, infertility and tumors
Karlberg, S. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 1
Smith, G. (2015) · Enlighten: Theses (The University of Glasgow)
Hereditary Renal Tumors of the Adult
Spruijt, L., & Hoogerbrugge, N. (2008) · Wiley eBooks · doi:10.1002/9783527627523.ch15
Functional analysis of the von Hippel-Lindau tumour suppressor in mice
Ballschmieter, P. (2005) · edoc (University of Basel) · doi:10.5451/unibas-003707005
Dehdashti, A. R., & Regli, L. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.027
Deubiquitinating Enzymes, Cell Proliferation, and Cancer
Baker, R. T. (2006) · Wiley eBooks · doi:10.1002/9783527620227.ch9
Hypoxia-Associated Regulation within Implantation Sites
Alahari, S., Caniggia, I., & Caniggia, I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394445-0.00018-7
A role for the ubiquitin domain protein HERP in ER-associated protein degradation
Schulze, A. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15575 · Cited by 1
Regulation of Myc oncoprotein function by E3 ubiquitin ligases
Fahlén, S. (2008) · Epsilon Open Archive (Sveriges lantbruksuniversitet biblioteket (Swedish University of Agricultural Sciences))
Other Cerebellopontine Angle Tumors
Samii, M., & Gerganov, V. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-35422-9_11
Functional analysis of the von Hippel-Lindau tumour suppressor and its role in tumourigenesis
Barry, R. E. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003376459
The role of Src kinase in renal cell carcinoma
Qayyum, T. (2014) · Enlighten: Theses (The University of Glasgow)
Genetic Counseling in Renal Masses
López‐Guerrero, J. A., García‐Casado, Z., Fernández‐Serra, A., & Rubio‐Briones, J. (2008) · Advances in Urology · doi:10.1155/2008/720840
The von Hippel-Lindau protein: a key player in oxygen homeostasis and matrix assembly
Esteban, M. A., Mandriota, S. J., & Maxwell, P. H. (2004) · International Congress Series · doi:10.1016/j.ics.2003.11.048 · Cited by 1
Gossage, L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1622-1_4 · Cited by 2
The stabilizing influence of VHL
Schuldt, A. J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc976
Von Hippel-Lindau (VHL) Syndrome: A Critical Insight
Behl, T., Kaur, I., Sudan, P., Sharma, M., & Goel, H. (2014) · Pharmatutor
A Case of von Hippel-Lindau Disease with Aortic Valve Insufficiency
Kang, S. H., Park, I., Cho, D. S., Lee, H. J., Lee, H. J., & Lee, D. H. (2013) · Journal of Yeungnam Medical Science · doi:10.12701/yujm.2013.30.2.101
Regulation of Angiogenesis by von Hippel Lindau Protein and HIF2
Bottaro, D. P., Tan, N., & Linehan, W. M. (2008) · Springer eBooks · doi:10.1007/978-0-387-71518-6_16
Müller, I. (2014) · Figshare
MOLECULAR ASPECTS OF ENDOTHELIAL CELL FUNCTION AND HYPOXIA-DEPENDENT TUMOR ANGIOGENESIS
Kucharzewska, P. (2011) · Lund University Publications (Lund University)
La conexina 43 como modulador de la captación de glucosa en astrocitos
Valle‐Casuso, J. C. (2010) · Gredos (University of Salamanca) · doi:10.14201/gredos.76585
Tests génétiques des syndromes des phéochromocytomes
Sokol, E. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72559-8
Hydrogen peroxide modulation of angiogenic factors in tumor cells
de Sousa, A. M. J. G. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Matos‐Ferreira, A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/a6pj-bz83
ReviewArticle Genetic Counseling in Renal Masses
Antônio, L. (2008)
Hitting the target with novel systemic therapies
Reaume, M. N., & Canil, C. M. (2007)
Dizziness and renal failure revealing the Von Hippel Lindau disease
Sekkouri, K. A., Alaoui, S. R., Batta, F. Z., Belghiti, K., Alaoui, H., El-Fadil, C., Arrayhani, & Husseini, T. (2015) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.168667
BILATERAL PHEOCHROMOCYTOMAS WITH VON HIPPEL-LINDAU DISEASE: A CASE REPORT
Masunaga, K., Inadome, A., Sugiyaa, Y., Maeda, Y., Satoji, Y., Takahashi, W., Yoshida, M., Ueda, S., Ikeda, K., Takano, Y., et al. (2007) · The Japanese Journal of Urology · doi:10.5980/jpnjurol1989.98.843
INTRAVITREAL BEVACIZUMAB FOLLOWED BY LASER PHOTOCOAGULATION FOR RETINAL CAPILLARY HEMANGINOBLASTOMAS
Pınarcı, E. Y., Karacal, H., & Demirel, B. (2011) · Retinal Cases & Brief Reports · doi:10.1097/icb.0b013e3182061cf4
PP6C Hotspot Mutations in Melanoma Display Sensitivity to
Gold, H. L., Wengrod, J., de Miera, E. V., Wang, D., Fleming, N. H., Sikkema, L., Kirchhoff, T., Hochman, T., Goldberg, J. D., Osman, I., et al. (2013)
Energy metabolism pathway related genes and adaptive evolution of tumor cells
Liu, J., & Kong, Q. (2013) · Zoological Research · doi:10.3724/sp.j.1141.2012.06557
Cutaneous Hamartoneoplastic Disorders
Nathanson, K. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00178-6
Darrouzet, V., Uziel, A. S., & Déguine, O. (2016) · Elsevier eBooks · doi:10.1016/b978-2-294-75213-1.00003-1
A Novel Role for Tid1 in HIF2α Regulation
Burnett, D. (2010) · TSpace (University of Toronto)
Role of Hypoxia-inducible Factor in Kidney Cancer
Roberts, A. M. (2012) · TSpace (University of Toronto)
Generation of a Murine Model for Renal Cell Carcinoma by Overexpression of HIF2α
Shah, N. A. (2013) · TSpace (University of Toronto)
Palmitoyl ascorbate-modified liposomes for the treatment of renal cell carcinoma
Deshpande, M. S. (2014) · Digital Repository Service (Northeastern University) · doi:10.17760/d20196652
pVHL Function Is Essential for Endothelial Extracellular
Tang, N., Mack, F. A., Haase, V. H., Simon, M. C., & Johnson, R. S. (2006)
Review Role of angiogenesis on bone formation
Portal‐Núñez, S., Lozano, D., & Esbrit, P. (2012)
Gnazzo, M. M., Villarreal, A. R., & Skop, A. R. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/173856
CYSTIC TRANSFORMATION OF THE PANCREAS DUE TO VON HIPPEL–LINDAU SYNDROME
Shikeeva, A. A., Lyadov, V. K., Kekeeva, T. V., & Mikhaylenko, D. S. (2017) · Annaly khirurgicheskoy gepatologii = Annals of HPB surgery · doi:10.16931/1995-5464.20172104-108
Pheochromocytomas and Paragangliomas: Genetics and Pathophysiology
Fishbein, L. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_8
Role of myeloid Hypoxia-Inducible Factor-1alpha in the tumor microenvironment
Doedens, A. L. (2008) · eScholarship (California Digital Library)
Philip, B. (2014) · Griffith Research Online · doi:10.25904/1912/1367
Src Regulation of von Hippel-Lindau Tumour Suppressor Protein
Chou, M. T.-H. (2009) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/17055
Die Von-Hippel-Lindau-Erkrankung (VHL): zur Erfassung und Betreuung Betroffener
Müller, H., Bürki, N., Gillessen, S., Gürtler, M., Imhof, H., Keller, U., Messmer, E. P., Schumacher, M., & Trutmann, E. (2006) · Swiss Medical Forum ‒ Schweizerisches Medizin-Forum · doi:10.4414/smf.2006.05763
Falcine meningioma in Von Hippel–Lindau disease: An unusual association
Murrone, D., Romanelli, B., Montemurro, N., Chirchiglia, D., & Ierardi, A. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_398_17
Unique Case of a Rare Mesenchymal Tumor Harboring a Somatic c.119delC VHL Mutation
Robbrecht, D. G. J., Atrafi, F., van Riet, J., Eskens, F. A. L. M., van Diest, P. J., Cuppen, E. P. J. G., van Leenders, G. J. L. H., van de Werken, H. J. G., & Lolkema, M. P. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00244
Zacharek, S. J. (2006) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tp9d-5n23
Die Reorganisation des Aktinzytoskeletts in Hypoxie: Neue Erkenntnisse über die Rolle von ArhGAP29
Peters, J. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7593
Ubiquitin Signaling and Cancer Pathogenesis
Haglund, K., & Đikić, I. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch1c
Nuevos casos de feocromocitoma en el hospital universitario de Neiva
Tovar, A. P., Diaz-Cardozo, E. M., Motta, O., & Castro, M. (2017) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.2.3.98
Hereditary Cancer Syndromes: Risk Assessment and Genetic Counseling
Webster, R. D., Bannon, S. A., Hyde, S. M., Woodson, A., You, N., Lu, K. H., & Arun, B. (2019) · Wiley eBooks · doi:10.1002/9781119000822.hfcm143
A case of von Hippel-Lindau disease with multi-organ involvement: a rare case report
Bhuyan, M., Saha, D., Baishya, B. K., & Ghanghoria, A. (2020) · International Surgery Journal · doi:10.18203/2349-2902.isj20201897
Greenberg, S. E., Maese, L. D., & Maughan, B. L. (2020) · Wiley eBooks · doi:10.1002/9781119432692.ch62
Prolifération fibrovasculaire papillaire dans la maladie de von Hippel-Lindau : à propos d’un cas
Kaoual, H., Braham, I. Z., Farhat, R., Boukari, M., & Zhioua, R. G. (2021) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2020.08.007
A Nonsense Mutation in VHL Gene Causing Von Hippel-lindau Syndrome in a Large Chinese FamilyPreprint
Ding, X., Liang, T., Li, B., Liang, B., Li, P., Chen, S., Li, J., Wang, F., Wang, S., Cao, Y., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-95115/v1
Novel targets for refractory kidney cancer: Where are we heading?
Sarkis, J., Sarkis, P., Alkassis, M., Assaf, J., & Ghazi, R. (2021) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552211027216
Neuroendocrine Neoplasms with Peculiar Biology and Features: MEN1, MEN2A, MEN2B, MEN4, VHL, NF1
Faggiano, A., Feola, T., Puliani, G., Sesti, F. F., & Giannetta, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-72830-4_17
Metadata
- Authors
- Kaelin, W. G.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kaelin, William G.
- ORCID
- Kaelin, William G.
- Venue
- Nature Reviews Cancer
- Published
- 2002-09
- Volume
- 2
- Issue
- 9
- Pages
- 673-682
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2093776019
- Semantic Scholar
- 6b13bcf0623256d5dceb071144a84d45b84f9a99
- Cited by
- 865
- References
- 146
- Citations by year
- 2026: 18 · 2025: 29 · 2024: 25 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 34 · 2019: 32 · 2018: 28 · 2017: 22 · 2016: 27 · 2015: 29 · 2014: 39 · 2013: 42 · 2012: 46
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Keywords
- von Hippel-Lindau disease, VHL gene, hereditary cancer, oxygen sensing, prolyl hydroxylation, hypoxia signaling, tumour suppressor, cancer therapy
- MeSH terms
- Animals, von Hippel-Lindau Disease, Humans, Ligases, Neoplasms, Gene Expression Regulation, Neoplastic, Genetic Predisposition to Disease, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.